 |
市場調査レポート
商品コード
1463474
医療用大麻の世界市場規模、シェア、成長分析、用途別、タイプ別 - 産業予測、2024～2031年Global Medical Cannabis Market Size, Share, Growth Analysis, By Application(Cancer, Pain Disorders and Others), By Type(Flower, Concentrates) - Industry Forecast 2024-2031 |
||||||
| 医療用大麻の世界市場規模、シェア、成長分析、用途別、タイプ別 - 産業予測、2024～2031年 |
|
出版日: 2024年04月08日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の医療用大麻の市場規模は、2022年に145億米ドルとなり、2023年の177億6,000万米ドルから、2031年までには900億7,000万米ドルに成長し、予測期間（2024～2031年）のCAGRは22.50%で成長する見通しです。
多くの国で医療用大麻が合法化されたことで、栽培への道が開かれ、輸入への依存度が下がり、税収が強化されました。インドでは2022年1月にデリー高等裁判所が医療・科学目的での大麻の使用を認める決定を下していることからも明らかなように、世界各国の政府が医療目的での大麻の使用を促進しています。広範な調査により、医療用大麻は従来の治療法に比べて慢性疼痛管理に効果的で安全な選択肢であることが示されており、その手頃な価格、天然由来、副作用のなさは特筆すべき利点です。特に、2022年5月の報告書に示されたように、成人のかなりの割合が慢性疼痛を経験していることを考慮すると、慢性疼痛管理における医療用大麻の有効性に関する現在進行中の研究は、市場の成長を後押しするものと思われます。医療用大麻市場は、研究努力の増大と医療上の利点の認識、法改正や知的財産権の進展と相まって、大幅に拡大すると予測されます。
目次
エグゼクティブサマリー
- 市場概要
- 運命の輪
調査手法
- 情報調達
- 二次・一次情報源
- 市場規模の推定
- 市場の前提条件と制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主要な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主要な投資の分析
- 主要な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
医療用大麻の世界市場：用途別
- 市場概要
- がん
- 疼痛障害
- その他
医療用大麻の世界市場：タイプ別
- 市場概要
- 花
- 濃縮物
- 食用
- その他
医療用大麻の世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他欧州地域
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
- ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
- 中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主要な市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Aurora Cannabis Inc.（Canada）
- Canopy Growth Corporation（Canada）
- GW Pharmaceuticals plc（UK）
- Tilray, Inc.（Canada）
- Aphria Inc.（Canada）
- MedReleaf Corp.（Canada）
- Cronos Group Inc.（Canada）
- Maricann Group Inc.（Canada）
- Emblem Corp.（Canada）
- CannTrust Holdings Inc.（Canada）
- Organigram Holdings Inc.（Canada）
- Hexo Corp.（Canada）
- Vivo Cannabis Inc.（Canada）
- TerrAscend Corp.（Canada）
- Harvest Health & Recreation Inc.（USA）
- Curaleaf Holdings, Inc.（USA）
- Trulieve Cannabis Corp.（USA）
- Columbia Care Inc.（USA）
- Green Thumb Industries Inc.（USA）
- Cresco Labs Inc.（USA）
- Acreage Holdings, Inc.（USA）
Global Medical Cannabis Market size was valued at USD 14.50 billion in 2022 and is poised to grow from USD 17.76 billion in 2023 to USD 90.07 billion by 2031, growing at a CAGR of 22.50% in the forecast period (2024-2031).
The legalization of medical marijuana in numerous countries has paved the way for its cultivation, reducing dependency on imports and bolstering tax revenue. Governments worldwide are facilitating the use of cannabis for medical purposes, as evidenced by the Delhi High Court's January 2022 decision permitting its use for medical and scientific ends in India. Extensive research has showcased medical cannabis as an effective and safer alternative for managing chronic pain compared to conventional treatments, with its affordability, natural origin, and lack of side effects being notable advantages. Ongoing studies on its efficacy in chronic pain management are poised to fuel market growth, especially considering the substantial portion of adults, as indicated in a May 2022 report, experiencing chronic pain. With increasing research endeavors and recognition of its medical merits, coupled with legal reforms and advancements in intellectual property rights, the medical cannabis market is projected to expand significantly.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Medical Cannabis Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Medical Cannabis Market Segmental Analysis
Global Medical Cannabis Market is segmented on the basis of type, application and region. By type, the market is segmented into flower, edible, concentrates, others. By application, market is segmented into cancer, pain disorders, others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Medical Cannabis Market
Cannabis has been authorized to address various conditions such as chemotherapy-induced nausea and vomiting, restlessness, muscle tension, and chronic discomfort. Research on the therapeutic potential of cannabis and hemp is rapidly progressing across many industries.
Restraints in the Global Medical Cannabis Market
Consequently, the development of cannabis capsules aims to provide precise and carefully measured doses of a blend of cannabis-based medicinal compounds. The demand for these precisely calibrated cannabis capsule dosages is expected to surge globally due to their potential to effectively address various health conditions such as Alzheimer's disease, cancer, epilepsy, glaucoma, PTSD, muscular spasms, and more.
Market Trends of the Global Medical Cannabis Market
The emergence of a diverse array of cannabis-infused products such as oils, tinctures, capsules, and topical creams reflects a notable trend in the industry. This expansion not only broadens the market but also appeals to a more diverse demographic of patients, indicating a growing interest and acceptance of cannabis-based remedies.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Medical Cannabis Market by Application
- Market Overview
- Cancer
- Pain Disorders and Others
Global Medical Cannabis Market by Type
- Market Overview
- Flower
- Concentrates
- Edible
- Others
Global Medical Cannabis Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Aurora Cannabis Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Canopy Growth Corporation (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GW Pharmaceuticals plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Tilray, Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Aphria Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MedReleaf Corp. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cronos Group Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Maricann Group Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Emblem Corp. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CannTrust Holdings Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Organigram Holdings Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hexo Corp. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Vivo Cannabis Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- TerrAscend Corp. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Harvest Health & Recreation Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Curaleaf Holdings, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Trulieve Cannabis Corp. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Columbia Care Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Green Thumb Industries Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cresco Labs Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Acreage Holdings, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
